Welcome to the international HTA database

Showing [16732 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dialysis modalities for the treatment of end-stage kidney disease: a health technology assessment
2017	Agency for Healthcare Research and Quality (AHRQ)	Interventions to prevent age-related cognitive decline, mild cognitive impairment, and clinical Alzheimer's-type dementia
2017	NIHR Health Services and Delivery Research programme	Quality and reporting standards, resources, training materials and information for realist evaluation: the RAMESES II project
2017	Agency for Healthcare Research and Quality (AHRQ)	Preventing complications and treating symptoms of diabetic peripheral neuropathy
2017	NIHR Health Services and Delivery Research programme	Optimal NHS service delivery to care homes: a realist evaluation of the features and mechanisms that support effective working for the continuing care of older people in residential settings
2017	NIHR Health Technology Assessment programme	Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction)
2017	Agency for Healthcare Research and Quality (AHRQ)	Assessment tools for palliative care
2017	NIHR Health Services and Delivery Research programme	Variations in mortality across the week following emergency admission to hospital: linked retrospective observational analyses of hospital episode data in England, 2004/5 to 2013/14
2017	Agency for Healthcare Research and Quality (AHRQ)	Treatment of osteoarthritis of the knee: an update review
2017	NIHR Public Health Research (PHR) programme	Assessing the impact and cost-effectiveness of needle/syringe provision and opiate substitution therapy on hepatitis C transmission among people who inject drugs in the United Kingdom: analysis of pooled datasets and economic modelling
2017	NIHR Health Technology Assessment programme	Timing of surgical intervention for developmental dysplasia of the hip: a randomised controlled trial (Hip 'Op)
2017	Agency for Healthcare Research and Quality (AHRQ)	Tympanostomy tubes in children with otitis media
2017	NIHR Public Health Research (PHR) programme	Adapting the ASSIST model of informal peer-led intervention delivery to the Talk to FRANK drug prevention programme in UK secondary schools (ASSIST + FRANK): intervention development, refinement and a pilot cluster randomised controlled trial
2017	NIHR Public Health Research (PHR) programme	Results of the First Steps study: a randomised controlled trial and economic evaluation of the Group Family Nurse Partnership (gFNP) programme compared with usual care in improving outcomes for high-risk mothers and their children and preventing abuse
2017	NIHR Health Technology Assessment programme	CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
2017	NIHR Public Health Research (PHR) programme	Could scale-up of parenting programmes improve child disruptive behaviour and reduce social inequalities? Using individual participant data meta-analysis to establish for whom programmes are effective and cost-effective
2017	National Institute for Health and Care Excellence (NICE)	Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib. NICE technology appraisal guidance 427
2017	NIHR Health Technology Assessment programme	Accessibility and implementation in the UK NHS services of an effective depression relapse prevention programme: learning from mindfulness-based cognitive therapy through a mixed-methods study
2017	National Institute for Health and Care Excellence (NICE)	Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy. NICE technology appraisal guidance 428
2017	National Institute for Health and Care Excellence (NICE)	Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation. NICE technology appraisal guidance 429
2017	Belgian Health Care Knowledge Centre (KCE)	Bevacizumab in the treatment of ovarian cancer
2017	National Institute for Health and Care Excellence (NICE)	Sofosbuvir-velpatasvir for treating chronic hepatitis C. NICE technology appraisal guidance 430
2017	National Institute for Health and Care Excellence (NICE)	Everolimus for advanced renal cell carcinoma after previous treatment. NICE technology appraisal guidance 432
2017	National Institute for Health and Care Excellence (NICE)	Apremilast for treating active psoriatic arthritis. NICE technology appraisal guidance 433
2016	NIHR Health Technology Assessment programme	Psychoeducation with problem-solving (PEPS) therapy for adults with personality disorder: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manualised intervention to improve social functioning
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Andexanet alfa for acute major bleeding episodes requiring reversal of anticoagulation, including reversal of factor Xa inhibition – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Intrathecal idursulfase (Elaprase) for Hunter syndrome (mucopolysaccharidosis type II)
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nusinersen for paediatric-onset spinal muscular atrophy – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for refractory myasthenia gravis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Voke 0.45mg inhaler for smoking cessation – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Crisaborole for adults, adolescents and children with atopic dermatitis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Netarsudil for open-angle glaucoma or ocular hypertension
2016	NIHR Health Technology Assessment programme	The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Mitomycin ophthalmic (Mitosol) for glaucoma surgery
2016	NIHR Health Services and Delivery Research programme	Improving skills and care standards in the support workforce for older people: a realist synthesis of workforce development interventions
2016	NIHR Health Services and Delivery Research programme	Integrated care to address the physical health needs of people with severe mental illness: a rapid review
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	An enhanced recovery after surgery program for hip and knee arthroplasty
2016	NIHR Health Technology Assessment programme	Modelling disease progression in relapsing remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort
2016	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	LINX reflux management system
2016	Agency for Healthcare Research and Quality (AHRQ)	Diabetes medications for adults with type 2 diabetes: an update
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Cryotherapy, radioablation and irreversible electroporation for prostate cancer
2016	Agency for Healthcare Research and Quality (AHRQ)	Imaging for the pretreatment staging of small cell lung cancer
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	CT to reduce negative appendectomy rates
2016	Belgian Health Care Knowledge Centre (KCE)	Left ventricular assist devices in the treatment of end-stage heart failure
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Retrograde endovascular balloon occlusion of the aorta (REBOA)
2016	NIHR Health Technology Assessment programme	UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	MicroVisualase Thermal Therapy System: MRI-guided laser ablation of neurologic tumourswave ablation for liver tumours
2016	NIHR Public Health Research (PHR) programme	Interventions to promote or maintain physical activity during and after the transition to retirement: an evidence synthesis
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Health Policy Advisory Committee on Technology (HealthPACT)
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Radiofrequency ablation for treating nasal hypertrophy of the inferior turbinates
2016	HAYES, Inc.	Balloon sinuplasty for treatment of chronic rhinosinusitis
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SureFire Precision Chemoembolization Infusion system keeps drugs within liver tumours
2016	HAYES, Inc.	Comparative effectiveness of bivalirudin versus heparin monotherapy for percutaneous coronary intervention (PCI)
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Argus II Retinal prosthesis
2016	Health Information and Quality Authority (HIQA)	A guide to health technology assessment at HIQA
2016	HAYES, Inc.	Electrical bone growth stimulation, invasive
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	BioZorb - an implantable device to delimit surgical site after lumpectomy in breast cancer
2016	HAYES, Inc.	High-frequency chest wall compression for diseases other than cystic fibrosis
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Wireless technology for LV pacing without coronary sinus
2016	NIHR Health Technology Assessment programme	Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study)
2016	HAYES, Inc.	Hyperbaric oxygen therapy for sudden sensorineural hearing loss
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Non-invasive open ventilation system
2016	NIHR Health Technology Assessment programme	The feasibility of determining the effectiveness and cost-effectiveness of medication organisation devices compared with usual care for older people in a community setting: systematic review, stakeholder focus groups and feasibility randomised controlled trial
2016	HAYES, Inc.	Indwelling pleural catheters for the management of malignant pleural effusions
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Ovation iX Abdominal Stent Graft System
2016	HAYES, Inc.	Minimally invasive surgical (MIS) procedures for treatment of atrial fibrillation
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Bioresorbable stents
2016	HAYES, Inc.	Minimally invasive transforaminal lumbar interbody fusion (mitlif) versus open transforaminal lumbar interbody fusion (otlif) for treatment of lumbar disc disease: a review of reviews
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ system for sentinel lymph node biopsy in breast cancer
2016	NIHR Health Services and Delivery Research programme	Equity of utilisation of cardiovascular care and mental health services in England: a cohort-based cross-sectional study using small-area estimation
2016	HAYES, Inc.	Nitric oxide breath analysis for the management of asthma
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Ga-68 prostate specific membrane antigen (PSMA) PET/CT
2016	NIHR Horizon Scanning Centre (NIHR HSC)	AXS 02 (zoledronic acid) for type I complex regional pain syndrome
2016	HAYES, Inc.	Noninvasive computed fractional flow reserve from computed tomography (FFRCT) for coronary artery disease
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Blinatumomab (Blincyto) for B-precursor acute lymphoblastic leukaemia minimal residual disease – patients in remission
2016	HAYES, Inc.	Noninvasive electrical bone growth stimulators for spinal fusion or foot and ankle indications
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Duvelisib for relapsed chronic lymphocytic leukaemia – second and subsequent line
2016	HAYES, Inc.	Patient-specific instruments for total knee arthroplasty: a review of reviews
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Duvelisib for relapsed follicular lymphoma - third and subsequent line
2016	HAYES, Inc.	Ultrasound-guided high-intensity focused ultrasound for primary treatment of localized prostate cancer
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Lenvatinib (Lenvima) for unresectable hepatocellular carcinoma – first line
2016	HAYES, Inc.	5-aminolevulinic acid photodynamic therapy versus carbon dioxide laser ablation for the treatment of condylomata acuminata
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for relapsed or refractory peripheral T-cell lymphoma
2016	HAYES, Inc.	Amniotic tissue–derived allografts for treatment of plantar fasciitis
2016	NIHR Health Technology Assessment programme	The Head Injury Transportation Straight to Neurosurgery (HITS-NS) randomised trial: a feasibility study
2016	NIHR Health Services and Delivery Research programme	Outpatient services and primary care: scoping review, substudies and international comparisons
2016	HAYES, Inc.	Bupivacaine liposome injectable suspension (Exparel; Pacira Pharmaceuticals Inc.) for treatment of postoperative pain in abdominal surgeries
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ursodeoxycholic acid (Ursofalk®)
2016	HAYES, Inc.	Carbon dioxide (CO2) laser ablation versus other surgical treatment of condylomata acuminata
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eribulin mesilate (Halaven®)
2016	HAYES, Inc.	Fecal microbiota transplant for refractory or recurrent Clostridium difficile infection in adults
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sorafenib (Nexavar®)
2016	HAYES, Inc.	Intersitial brachytherapy for the treatment of nonmelanoma skin cancer
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ulipristal acetate (Esmya®)
2016	Agency for Healthcare Research and Quality (AHRQ)	Omega-3 fatty acids and cardiovascular disease: an updated systematic review
2016	HAYES, Inc.	Laser balloon ablation for treatment of atrial fibrillation
2016	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Prucalopride (Resolor®)
2016	Agency for Healthcare Research and Quality (AHRQ)	Strategies to de-escalate aggressive behavior in psychiatric patients
2016	HAYES, Inc.	Low frequency right transcranial magnetic stimulation for major depressive disorder